Order Article Reprints

Kannan S, Irwin ME, Herbrich SM, Cheng T, Patterson LL, Aitken MJL, Bhalla K, You MJ, Konopleva M, Zweidler-McKay PA, et al. Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy. Antioxidants. 2022; 11(4):717. https://doi.org/10.3390/antiox11040717

Kannan, Sankaranarayan, Mary E. Irwin, Shelley M. Herbrich, Tiewei Cheng, LaNisha L. Patterson, Marisa J. L. Aitken, Kapil Bhalla, M. James You, Marina Konopleva, Patrick A. Zweidler-McKay, and et al. 2022. "Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy" Antioxidants 11, no. 4: 717. https://doi.org/10.3390/antiox11040717

Kannan, S., Irwin, M. E., Herbrich, S. M., Cheng, T., Patterson, L. L., Aitken, M. J. L., Bhalla, K., You, M. J., Konopleva, M., Zweidler-McKay, P. A., & Chandra, J. (2022). Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy. Antioxidants, 11(4), 717. https://doi.org/10.3390/antiox11040717